Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
CardioVascular BioTherapeutics, Inc. |
---|---|
Information provided by: | CardioVascular BioTherapeutics, Inc. |
ClinicalTrials.gov Identifier: | NCT00425178 |
FGF-1 is being used for the treatment of patients with diabetic or venous stasis ulcers. Procedure includes topical administration of FGF-1 or placebo and evaluation of safety, pharmacokinetics, and wound improvement.
Condition | Intervention | Phase |
---|---|---|
Chronic Wounds Diabetes Venous Stasis Ulcers |
Drug: FGF-1 |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase 1, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Patients With Diabetic or Venous Stasis Ulcers |
Enrollment: | 8 |
Study Start Date: | September 2005 |
Patients meeting eligibility criteria will be randomized to receive topical administration of either FGF-1 or placebo. Patients will be evaluated at days 1 and 7, post-treatment for safety, pharmacokinetics, and wound healing.
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Eligibility Criteria:
United States, Pennsylvania | |
Warren General Hospital | |
Warren, Pennsylvania, United States, 16365 |
Principal Investigator: | Thomas E Serena, MD | Warren General Hospital |
Study ID Numbers: | CVBT-W2005-01 |
Study First Received: | January 18, 2007 |
Last Updated: | January 7, 2008 |
ClinicalTrials.gov Identifier: | NCT00425178 |
Health Authority: | United States: Food and Drug Administration |
Chronic wounds Diabetes Ulcers |
Arterial bypass Angioplasty Diabetic ulcers |
Peripheral Vascular Diseases Skin Diseases Ulcer Diabetes Mellitus Vascular Diseases Postthrombotic Syndrome Thrombosis Varicose Ulcer Embolism and Thrombosis |
Varicose Veins Embolism Phlebitis Venous Insufficiency Venous Thrombosis Skin Ulcer Postphlebitic Syndrome Leg Ulcer |
Pathologic Processes Cardiovascular Diseases |